Pediatrician, Psychologist, Fellow, Resident, Nurse, Other
Participants will be able to:
Educational Objective:
To RECOGNIZE the various faces (“phenotypes”) of sudden death predisposing cardiomyopathies and channelopathies including hypertrophic cardiomyopathy (HCM) and long QT syndrome (LQTS)
To ASSESS the currently available genetic tests for HCM and LQTS and EVALUATE their yield and role
To INTERPRET genetic tests and INCORPORATE them into the practice of personalized medicine as probabilistic tests
Presenters:
Michael J Ackerman, M.D., PhD, Professor of Medicine, Pediatrics, and Pharmacology, Mayo Clinic, Director, Long QT Syndrome/Genetic Heart Rhythm Clinic and Mayo, Clinic Windland Smith Rice Sudden Death Genomics Laboratory
Transgenomic, Royalties, Intellectual Property
Contact
- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.